Karin Breunig

Karin Breunig is a notable inventor based in Halle/Saale, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines using recombinant yeast technology. With a total of three patents to her name, her work has the potential to impact public health positively.

Latest Patents

Karin Breunig's latest patents include an optimized host/vector system for producing protective mono- and multivalent subunit vaccines based on yeast. This invention relates to recombinant yeasts capable of efficiently expressing one or more foreign proteins, making them suitable for generating a protective immune response against various pathogens. The invention provides strains for the targeted cloning of foreign antigen-coding nucleic acids into the yeast genome, characterized by integrated expression cassettes for foreign antigens. Additionally, she has developed methods for producing these strains and their use as vaccines. Another significant patent involves the production of a humoral immune response against defined antigens using recombinant yeasts, which can be utilized for protective vaccination against pathogens and malignant cells.

Career Highlights

Throughout her career, Karin Breunig has worked with prominent organizations, including Verovaccines GmbH and Martin-Luther-University Halle-Wittenberg. Her work in these institutions has allowed her to advance her research and contribute to the field of vaccine development.

Collaborations

Karin has collaborated with notable colleagues such as Sven-Erik Behrens and Hans Caspar Hührlimann. These collaborations have further enriched her research and innovations in the field.

Conclusion

Karin Breunig's contributions to vaccine development through her innovative patents and collaborations highlight her significant role in biotechnology. Her work continues to pave the way for advancements in protective immunization strategies.

This text is generated by artificial intelligence and may not be accurate.